Cilengitide in Treating Patients With Unresectable or Metastatic Melanoma

Summary

This randomized phase II trial is studying how well cilengitide works in treating patients with unresectable stage III or stage IV melanoma. Cilengitide may stop the growth of melanoma by stopping blood flow to the tumor.

Timeline

Start

2004-03

Primary completion

2006-07

Completion

—

Drugs

Indications